Predicting Transfers to Hemodialysis in Peritoneal Dialysis Patients Using the Surprise Question
NCT ID: NCT04666844
Last Updated: 2022-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2019 participants
OBSERVATIONAL
2020-11-20
2022-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peritoneal Dialysis Daily Versus Six Days Per Week
NCT06399848
"Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"
NCT07338435
Urgent-start Peritoneal Dialysis in ESRD Patients：A Multi-center Study
NCT02946528
Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology
NCT00407134
Assisted Peritoneal Dialysis: A Feasibility Study
NCT04319185
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Will the participant be surprised if this patient transfers to hemodialysis in the next 6 months?
2. Will the participant be surprised if this patient dies in the next 6 months?
Patients will be followed for 6 months for outcomes (with two extra months for ascertainment of outcomes).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survey
Clinicians will be asked to provide responses to the two surprise questions for each of their PD patients.
no intervention
Observational Study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
Observational Study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients already enrolled in hospice
* Patients on PD training
* Patients on backup hemodialysis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Satellite Healthcare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wael Hussein, MBBS
Senior Director of Clinical Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wael Hussein
Role: PRINCIPAL_INVESTIGATOR
Satellite Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Satellite Healthcare Inc
San Jose, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIH126_PD Suprise Question
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.